The changes in RNA splicing during early liver disease were significantly enriched for targets of the splicing factor SRSF3, which is consistent with our previously published finding that the SRSF3 protein is degraded during lipid overload or in NAFLD in both human and mouse samples29. Here, SRSF3 is linked to metabolic dysfunction-associated steatotic liver disease.